Jankovic–Rivera syndrome
Jankovic–Rivera syndrome is a rare neurological disorder characterized by adult-onset muscle weakness, tremors, and Parkinsonism. It is named after the two physicians, Dr. Joseph Jankovic and Dr. Salvador Rivera, who first described the syndrome in 2001.
Etiology[edit | edit source]
The exact cause of Jankovic–Rivera syndrome is currently unknown. However, it is believed to be a genetic disorder, as it often appears in multiple members of the same family. Some researchers suggest that it may be caused by a mutation in a gene that is involved in the function of neurons.
Symptoms[edit | edit source]
The symptoms of Jankovic–Rivera syndrome typically begin in adulthood. The most common symptoms include muscle weakness, tremors, and signs of Parkinsonism such as bradykinesia (slowness of movement), rigidity, and postural instability. Some patients may also experience dysphagia (difficulty swallowing), dysarthria (difficulty speaking), and dystonia (involuntary muscle contractions).
Diagnosis[edit | edit source]
Diagnosis of Jankovic–Rivera syndrome is based on the presence of characteristic symptoms, a family history of the disorder, and the exclusion of other neurological disorders. There is currently no specific diagnostic test for the syndrome.
Treatment[edit | edit source]
There is no cure for Jankovic–Rivera syndrome. Treatment is symptomatic and may include medications to manage tremors and Parkinsonism, physical therapy to improve muscle strength and mobility, and speech therapy to manage dysarthria and dysphagia.
Prognosis[edit | edit source]
The prognosis for individuals with Jankovic–Rivera syndrome varies. Some individuals may experience a slow progression of symptoms over many years, while others may experience a more rapid progression of the disease.
See also[edit | edit source]
NIH genetic and rare disease info[edit source]
Jankovic–Rivera syndrome is a rare disease.
Jankovic–Rivera syndrome Resources | |
---|---|
|
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
WikiMD's Wellness Encyclopedia |
Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD